ALLR Allarity Therapeutics, Inc.
$1.03
Allarity Therapeutics, Inc. (ALLR) Earnings News
Earnings press releases, previews and reviews for Allarity Therapeutics, Inc. (ALLR), newest first.
Friday
August 14, 2026
8:00 AM ET
Allarity Therapeutics Reports Second Quarter 2026 Results and Completion of the Phase 3-Ready Stenoparib Manufacturing Campaign
Friday
May 15, 2026
4:30 PM ET
Allarity Therapeutics Reports First Quarter 2026 Results and Continued Stenoparib Development in Multiple Cancers
Tuesday
March 31, 2026
8:00 AM ET
Allarity Therapeutics Reports Full Year 2025 Financial Results and Corporate Progress